2025 annual financial data
Sunshine Biopharma 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -14.68%.
Operating income was -4,478,782 USD and net income was -5,975,352 USD.
Operating cash flow was -5,331,073 USD.
Get free Sunshine Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,305,891 USD
- Operating income
- -4,478,782 USD
- Net income
- -5,975,352 USD
- Operating cash flow
- -5,331,073 USD